Here is the original post:

GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh